<DOC>
	<DOCNO>NCT01428843</DOCNO>
	<brief_summary>Anemia frequently extradigestive symptom Inflammatory Bowel Disease . This due iron deficiency inflammation . Most treatment aim control inflammation use anti-TNF alpha therapy theorically reduce anemia . The aim study show perfusion iron associate anti-TNF therapy reduce anemia improve quality life patient .</brief_summary>
	<brief_title>Comparison Ferrisat v Placebo Anemia Associated Inflammatory Bowel Disease During Anti-TNF Therapy</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Age great 18 year Crohn 's disease Ulcerative Colitis define accord usual endoscopic , histological , radiological criterion Under antiTNF therapy indication start antiTNF therapy Anemia define accord World Health Organization ( Hemoglobin 13g/dl man Hemoglobin 12g/dl woman ) Iron deficiency anemia define : Ferritinemia 100 CReactive Protein normal value OR Ferritinemia 30 100 CReactive Protein normal value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Anemia</keyword>
	<keyword>Anti-TNF alpha theray</keyword>
	<keyword>Ferrisat perfusion</keyword>
</DOC>